ArticleJournal of pharmaceutical analysis2026

Aptamer-based nanoparticle drug delivery system designed for targeting GPC3-positive liver cancer.

Hongxin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.